Physician Wealth Advisors’s Summit Therapeutics SMMT Stock Holding History
Bought
Maintained
Sold
Other funds holding SMMT
BBA
KCM
Physician Wealth Advisors's SMMT Position: Q3 2026 in Review
Physician Wealth Advisors held its Summit Therapeutics (SMMT) position steady in Q3 2026 at 35 shares worth $592. The position accounts for ﹤0.01% of the portfolio, ranked #2153.
Physician Wealth Advisors first reported a position in SMMT in Q2 2025 and has held it in 5 quarters since. The position peaked at $1.17K in Q2 2025. 294 funds tracked by Wall St. Rank hold SMMT as of Q3 2026.
- Physician Wealth Advisors held 35 shares of Summit Therapeutics worth $592 as of Q3 2026.
- Physician Wealth Advisors left its Summit Therapeutics share count unchanged in Q3 2026.
- Summit Therapeutics made up ﹤0.01% of Physician Wealth Advisors's portfolio in Q3 2026, its #2153 holding.
- Physician Wealth Advisors first reported a position in Summit Therapeutics in Q2 2025 and has held it in 5 quarters since.
- Physician Wealth Advisors's Summit Therapeutics position peaked at $1.17K in Q2 2025.
- 294 funds tracked by Wall St. Rank held Summit Therapeutics as of Q3 2026.
Based on Physician Wealth Advisors's 13F filing for Q3 2026, filed 20 Oct 2026.